# A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways

> **NCT06741657** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 404 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Litifilimab
- **DEVICE:** AI
- **DEVICE:** OBI
- **DEVICE:** PFS

## Key facts

- **NCT ID:** NCT06741657
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-02
- **Primary completion:** 2026-03-10
- **Final completion:** 2026-03-10
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741657, "A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06741657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
